SCHEMBL17666289

SCHEMBL17666289

CCn1cc(-c2ccc(C)cc2C)cn1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LRRK2 Q5S007 1/20 0.57
PIM1 P11309 1/20 0.43
PRKACA P17612 1/20 0.41
PRKACG P22612 1/20 0.41
PRKACB P22694 1/20 0.41
PIK3CD O00329 1/20 0.41
PIK3CA P42336 1/20 0.41
PIK3CB P42338 1/20 0.41
PI4KA P42356 1/20 0.41
PIK3CG P48736 1/20 0.41
PI4KB Q9UBF8 1/20 0.41
PDK2 Q15119 2/20 0.40
ROCK2 O75116 1/20 0.40
ROCK1 Q13464 1/20 0.40
CDC42BPB Q9Y5S2 1/20 0.40
PDE3B Q13370 1/20 0.40
PDE3A Q14432 1/20 0.40
MAPK1 P28482 1/20 0.39
LMNA P02545 2/20 0.39
KDM4E B2RXH2 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27901959 0.84 LRRK2 (0.51) LRRK2PRKACAPRKACGPRKACBPDK2
SCHEMBL16983116 0.84 KCNH2 (0.50) LRRK2PRKACAPRKACGPRKACBPIK3CD
SCHEMBL16261238 0.82 LRRK2 (0.52) LRRK2PIM1PRKACAPRKACGPRKACB
SCHEMBL18193018 0.79 ALDH1A1 (0.45) LRRK2PRKACAPRKACGPRKACBPIK3CA
SCHEMBL11962892 0.78 LRRK2 (0.54) LRRK2PIM1CREBBP
SCHEMBL17809809 0.78 LRRK2 (0.64) LRRK2PIM1PIK3CDPIK3CAPIK3CB
SCHEMBL19998625 0.77 LRRK2 (0.50) LRRK2PIM1PRKACAPRKACGPRKACB
SCHEMBL28361337 0.77 LRRK2 (0.39) LRRK2LMNAKDM4EALDH1A1MAPT
SCHEMBL24342417 0.75 PIK3CD (0.48) LRRK2PIM1PIK3CDPIK3CAPIK3CB
SCHEMBL11983532 0.74 PIM1 (0.69) LRRK2PIM1PIK3CDPIK3CAPIK3CB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170002006-A1 MACROCYCLES WITH HETROCYCLIC P2' GROUPS AS FACTOR XIA INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2017-01-05 US disclosed
US-9453018-B2 Pyrimidinones as factor XIa inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2016-09-27 US disclosed
US-20160096839-A1 PYRIMIDINONES AS FACTOR XIA INHIBITORS BRISTOL-MYERS SQUIBB COMPANY 2016-04-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170002006-A1 MACROCYCLES WITH HETROCYCLIC P2' GROUPS AS FACTOR XIA INHIBITORS TFPI2, F2, TFPI LRRK2 1582/4885PIM1 4344/4885PRKACA 540/4885
US-20160096839-A1 PYRIMIDINONES AS FACTOR XIA INHIBITORS TFPI, TFPI2, F2 LRRK2 1178/4885PIM1 1538/4885PRKACA 527/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.